Prospect of Stem Cells as Promising Therapy for Brachial Plexus Injury: A Systematic Review.
brachial plexus injury
promising therapy
stem cell
Journal
Stem cells and cloning : advances and applications
ISSN: 1178-6957
Titre abrégé: Stem Cells Cloning
Pays: New Zealand
ID NLM: 101535817
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
02
2022
accepted:
11
05
2022
entrez:
30
6
2022
pubmed:
1
7
2022
medline:
1
7
2022
Statut:
epublish
Résumé
Brachial plexus injury is an advanced and devastating neurological injury, for which both nerve surgery and tendon transfers sometimes remain insufficient in restoring normal movement. Stem cell therapy may be applicable to rescue the injured motor neurons from degeneration which potentially improves muscle strength. Systematic Review; Level of evidence V. A systematic literature search was conducted on PubMed (MEDLINE), EMBASE, the Cochrane Library, and Scopus using the terms ("stem cell") AND ("brachial plexus") as search keywords. The process of study selection was summarized by PRISMA flow diagram. The study included in vivo and in vitro studies with English language, humans or animals with some brachial plexus injuries, interventions, some applications of stem cells to the groups of study, with functional, biomechanical, or safety outcomes. In total, there were 199 studies identified from the literature sources where 75 articles were qualified for forward evaluation following selecting the titles and abstracts. Ten studies were finally included in this systematic review after full-text assessment. Stem cells can produce neurotrophic factors in vitro and in vivo in rats, and their level was increased after injury. Electrophysiological measurement showed that the intervention group had distinctly higher CMAP amplitude and evidently shorter CMAP latency than the model group. Application of bone marrow stem cells (BMSCs) showed an elevation in the numbers of axons and density of myelinated fibers, the density of nerve fibers, the diameter of regenerating axons, and a decrease in axonal degeneration. A study in humans indicated an improvement of the movements in a patient with traumatic total BPI after injection of Ad-MSC. It is associated with increased muscle mass and sensory recovery and also suggested that mononuclear cell injection enhances muscle regeneration and reinnervation in the partly denervated muscle of brachial plexus injury. Various muscle groups had obtained strength together with restoration, the muscle strength attained after the previous transplantation were preserved. The results of this review support stem cell treatment in brachial plexus injury. This review provides evidence of the positive effects of stem cell treatment in brachial plexus injury.
Sections du résumé
Background
UNASSIGNED
Brachial plexus injury is an advanced and devastating neurological injury, for which both nerve surgery and tendon transfers sometimes remain insufficient in restoring normal movement. Stem cell therapy may be applicable to rescue the injured motor neurons from degeneration which potentially improves muscle strength.
Study Design
UNASSIGNED
Systematic Review; Level of evidence V.
Data Sources
UNASSIGNED
A systematic literature search was conducted on PubMed (MEDLINE), EMBASE, the Cochrane Library, and Scopus using the terms ("stem cell") AND ("brachial plexus") as search keywords.
Methods
UNASSIGNED
The process of study selection was summarized by PRISMA flow diagram. The study included in vivo and in vitro studies with English language, humans or animals with some brachial plexus injuries, interventions, some applications of stem cells to the groups of study, with functional, biomechanical, or safety outcomes.
Results
UNASSIGNED
In total, there were 199 studies identified from the literature sources where 75 articles were qualified for forward evaluation following selecting the titles and abstracts. Ten studies were finally included in this systematic review after full-text assessment. Stem cells can produce neurotrophic factors in vitro and in vivo in rats, and their level was increased after injury. Electrophysiological measurement showed that the intervention group had distinctly higher CMAP amplitude and evidently shorter CMAP latency than the model group. Application of bone marrow stem cells (BMSCs) showed an elevation in the numbers of axons and density of myelinated fibers, the density of nerve fibers, the diameter of regenerating axons, and a decrease in axonal degeneration. A study in humans indicated an improvement of the movements in a patient with traumatic total BPI after injection of Ad-MSC. It is associated with increased muscle mass and sensory recovery and also suggested that mononuclear cell injection enhances muscle regeneration and reinnervation in the partly denervated muscle of brachial plexus injury. Various muscle groups had obtained strength together with restoration, the muscle strength attained after the previous transplantation were preserved. The results of this review support stem cell treatment in brachial plexus injury.
Conclusion
UNASSIGNED
This review provides evidence of the positive effects of stem cell treatment in brachial plexus injury.
Identifiants
pubmed: 35770243
doi: 10.2147/SCCAA.S363415
pii: 363415
pmc: PMC9234311
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
29-42Informations de copyright
© 2022 Sumarwoto et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Neurotrauma. 2009 Jan;26(1):67-80
pubmed: 19196181
Mol Med Rep. 2013 May;7(5):1523-7
pubmed: 23545781
Top Spinal Cord Inj Rehabil. 2018 Summer;24(3):275-287
pubmed: 29997430
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1515-1523
pubmed: 32096201
Biomed J. 2013 May-Jun;36(3):98-105
pubmed: 23806879
Neural Regen Res. 2015 Feb;10(2):260-5
pubmed: 25883625
Cell Transplant. 2011;20(2):167-76
pubmed: 20719091
Microsurgery. 2014 Feb;34(2):91-101
pubmed: 23913440
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Stem Cells. 2006 Apr;24(4):1011-9
pubmed: 16339643
Biomed J. 2014 Jul-Aug;37(4):237-40
pubmed: 25116721
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
Adv Biomed Res. 2018 Mar 27;7:51
pubmed: 29657936
Bone Joint Res. 2014 Feb 24;3(2):38-47
pubmed: 24565688
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Exp Neurol. 2013 Oct;248:491-503
pubmed: 23891888
Nat Commun. 2021 Jan 29;12(1):692
pubmed: 33514709
Nat Commun. 2018 Jan 8;9(1):84
pubmed: 29311559
Mol Cell Proteomics. 2016 Feb;15(2):394-408
pubmed: 26695766
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
Chin J Traumatol. 2008 Oct;11(5):267-73
pubmed: 18822188
Neural Regen Res. 2019 Nov;14(11):1932-1940
pubmed: 31290451
NPJ Regen Med. 2020 May 11;5:10
pubmed: 32411395
Neural Regen Res. 2017 Dec;12(12):2106-2112
pubmed: 29323053
Gene Ther. 2002 May;9(10):613-24
pubmed: 12032707
Front Neurosci. 2019 Sep 06;13:952
pubmed: 31555087
Exp Neurol. 2003 Oct;183(2):610-9
pubmed: 14552902
Front Cell Dev Biol. 2017 May 12;5:52
pubmed: 28553634
Radiographics. 2006 Oct;26 Suppl 1:S133-43
pubmed: 17050511
Front Neurosci. 2019 Aug 02;13:790
pubmed: 31427916
Neural Regen Res. 2012 Aug 15;7(23):1786-90
pubmed: 25624802